Decreased narcotic use with an implantable local anesthetic catheter after deep inferior epigastric perforator flap breast reconstruction.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 19461271.
- Also identified by DOI 10.1097/SAP.0b013e31817fe61c.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study evaluated narcotic use after deep inferior epigastric perforator flap breast reconstruction when a local anesthetic catheter was used. A retrospective analysis was performed comparing 40 consecutive control patients (no catheter) to 40 consecutive study patients who had received a pain pump catheter. The catheter was left in the abdomen for 72 hours. Using an equianalgesic table, all narcotic doses (oral and intravenous) were converted to intravenous morphine equivalents. Initial average 24-hour morphine requirement for the control group was 42 mg compared with 33 mg for the study group (P = 0.04). Total hospitalization average morphine requirement for the control group was 71 mg compared with 55 mg for the catheter group (P = 0.03). The use of an implantable local anesthetic catheter placed in the abdomen can decrease narcotic use in the postoperative period after deep inferior epigastric perforator flap breast reconstruction.
Medical subject headings
- Analgesics, Opioid
- Breast Neoplasms
- Mammaplasty
- Postoperative Pain
- Surgical Flaps